Prohibit WP2 – systematic review of national guidelines in European countries by Martin, M et al.
POSTER PRESENTATION Open Access
Prohibit WP2 – systematic review of national
guidelines in European countries
M Martin
1*, C Wilson
1, W Zingg
2, S Hansen
3, P Gastmeier
3, D Pittet
2, M Dettenkofer
1, PROHIBIT consortium
From International Conference on Prevention & Infection Control (ICPIC 2011)
Geneva, Switzerland. 29 June – 2 July 2011
Introduction / objectives
The European Commission (FP-7) funded project PRO-
HIBIT (Prevention of Hospital Infections by Interven-
tion and Training) was established in 2010. WP2 of
PROHIBIT aims to analyse existing national guidelines,
practices in surveillance and public reporting of health-
care associated infections (HAI) in Europe.
Methods
The ECDC-HAI surveillance National Contact Points
(NCP) and experts in 34 countries (27 EU member
states, whereby UK counts as 4 countries, Croatia, Ice-
land, Norway and Switzerland) were invited to complete
a questionnaire and give information about existing
national guidelines for prevention of surgical site infec-
tion (SSI), ventilator-associated pneumonia (VAP),
catheter-associated urinary tract infection (CAUTI),
catheter- associated blood stream infection (CA-BSI)
and C. difficile infection (CDI). The NCPs were
requested to state where the guidelines could be found
in print or online. Stated websites were searched and
compared to answers. In cases of mismatch NCPs were
personally contacted for clarification.
Results
End of March 2011 32 NCPs (94%) completed the ques-
tionnaire. 14 countries have guidelines on all 5 topics. 7
countries have 4 guidelines, 1 has 3 and 4 have 1. 5
countries have no national guidelines. Scientific level of
supporting evidence and strength of recommendation
are stated in 51% of the guidelines. In most countries
identification of relevant documents was only possible
by personal communication with NCPs. Scope, structure
and detailing of recommendations vary widely.
Conclusion
Evidence-based, national guidelines for prevention of
HAI are still to be developed in many European coun-
tries. In the majority of countries finding the currently
valid guidelines may be difficult for users.
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